1. Introduction {#sec1-antioxidants-09-00128}
===============

Plants have played a pivotal role in the progress of mankind, being considered as a substantial source of food and medicine. Traditionally used, for their curative properties among different populations of the world, medicinal plants are still considered to provide outstanding curative effects and they remain the most accessible therapeutic approach to a number of ailments. In traditional medicine, herbal remedies are prepared according to "standardized formula" transmitted from elders or shamans. Some of the preparation methods include decoction, infusion, maceration, tinctures, among others which can be administered by different routes, including optical, dermal, oral, nasal, and anal \[[@B1-antioxidants-09-00128]\]. The WHO has publicized the need for documentation of ethnomedicinal data on plants, being conscious of the wealth of traditional knowledge that is related to medicinal use represents. Ethnomedicinal records make scientific validation easier and also provide rational regarding the use of plants/herbal preparations for the management of specific ailments \[[@B2-antioxidants-09-00128]\]. Global public interest for plants-derived products has undoubtedly increased and, today, one of the challenges is to provide scientific evidences of claimed biological activity, but also to unlock the potential of underexplored medicinal plants.

Recently, several endeavors have been made to probe for new sources of bioactive compounds from natural raw materials \[[@B3-antioxidants-09-00128],[@B4-antioxidants-09-00128]\]. Among them, the bark of plants is one of the most important sources of bioactive compounds, including phenolics, flavonoids, and terpenes. In addition, extracts that were prepared from barks have been reported to possess broad biological activities, such as antioxidant, antimicrobial, or anti-cancer \[[@B3-antioxidants-09-00128],[@B4-antioxidants-09-00128],[@B5-antioxidants-09-00128],[@B6-antioxidants-09-00128],[@B7-antioxidants-09-00128]\]. Based on these data, new studies on uninvestigated bark samples, particularly from Africa, might lead to the discovery of novel bioactive compounds for potential uses in the nutraceutical and pharmaceutical industries.

The *Bridelia* genus consists of approximately 60--70 species distributed in tropical and subtropical regions of the globe, particularly in Asia and Africa \[[@B8-antioxidants-09-00128]\]. Several species of this genus have been used in traditional medicinal systems for the management of multiple diseases, including diabetes, urinary stones, lumbago, rheumatism, venereal diseases, bronchitis, gastrointestinal problems, cardiac pain, infertility, epilepsy, and diarrhoea, among others \[[@B9-antioxidants-09-00128]\]. Keeping this in view, the biological efficacy of several *Bridelia* species has been claimed in several research pieces \[[@B10-antioxidants-09-00128],[@B11-antioxidants-09-00128],[@B12-antioxidants-09-00128],[@B13-antioxidants-09-00128],[@B14-antioxidants-09-00128],[@B15-antioxidants-09-00128]\]. In earlier studies, the chemical profiles of the members of the *Bridelia* genus have been reported. For example, previous studies have reported the presence of phenolic acids (gallic acid and ellagic acid, etc.), tannins, and flavonoids in several *Bridelia* species, including *B. ferruginea, B. micrhanta,* and *B. retusa.* Such studies also highlighted the importance of the *Bridelia* genus, which could open avenues for new studies \[[@B16-antioxidants-09-00128],[@B17-antioxidants-09-00128],[@B18-antioxidants-09-00128]\].

As far as our literature search could ascertain, little scientific information was available on *B. speciosa*. In this perspective, the current work aims at characterizing the stem bark extracts of *B. speciosa* investigating phytocompounds and elucidating the antioxidant, enzyme inhibitory properties, protective and anti-proliferative effects in experimental models of liver cancer and inflammation.

2. Materials and Methods {#sec2-antioxidants-09-00128}
========================

2.1. Plant Material and Preparation of Extracts {#sec2dot1-antioxidants-09-00128}
-----------------------------------------------

The plant samples were collected from wild areas in Gontougo region (Nioumassi) of Ivory Coast in 2018 and they were identified by Dr. Kouadio Bene, botanist at the Laboratoire de Botanique et Phytothérapie, Université Nangui Abrogoua, Abidjan, Côte d'Ivoire. A voucher specimen of the plant material was deposited at Selcuk University, Science Faculty (KIS-1005). The stem barks samples were randomly collected from ten plants in a same population. The stem barks samples were taken stripped vertically while using a knife to the limit of the cambium layer. The stem barks were separated and then dried at room temperature for ten days.

One laboratory mill (Retsch Cutting Mill SM 200, Haan, Germany) was used to powder them (about 2 mm). The extraction procedure was conducted following traditional maceration (for ethyl acetate and methanol) and infusion (for water) methods. Briefly, for maceration, 5 g powdered plant samples was stirred with solvents (100 mL) overnight at the room temperature. Subsequently, the solvents were evaporated using a rotary-evaporator. For water extracts, 5 g powdered plants in boiled water (100 mL) was allowed to stand for 20 min. The aqueous extract was then lyophilized and all of the extracts were kept in +4 °C until use.

2.2. Chemicals {#sec2dot2-antioxidants-09-00128}
--------------

The chemicals were purchased from Sigma--Aldrich (Darmstadt, Germany). They were: 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid (ABTS), 1,1-diphenyl-2-picrylhydrazyl (DPPH), gallic acid, rutin, caffeic acid, electric eel acetylcholinesterase (AChE) (type-VI-S, EC 3.1.1.7), horse serum butyrylcholinesterase (BChE) (EC 3.1.1.8), galantamine, acetylthiocholine iodide (ATChI), butyrylthiocholine chloride (BTChI) 5,5-dithio-bis(2-nitrobenzoic) acid (DTNB), tyrosinase (EC1.14.18.1, mushroom), glucosidase (EC. 3.2.1.20, from *Saccharomyces cerevisiae*), amylase (EC. 3.2.1.1, from porcine pancreas), sodium molybdate, sodium nitrate, sodium carbonate, Folin-Ciocalteu reagent, hydrochloric acid, sodium hydroxide, trolox, EDTA, neocuproine, cupric chloride, ammonium acetate, ferric chloride, 2,4,6-Tris(2-pyridyl)-s-triazine (TPTZ), ammonium molybdate, ferrozine, ferrous sulphate hexahydrate, kojic acid and acarbose. All of the chemicals were of analytical grade.

2.3. Phytochemical Composition {#sec2dot3-antioxidants-09-00128}
------------------------------

The total bioactive compounds were determined colorimetrically, as described previously \[[@B19-antioxidants-09-00128],[@B20-antioxidants-09-00128],[@B21-antioxidants-09-00128]\]. The results were expressed as mg of standard compounds (gallic acid for phenolic; and rutin for flavonoids; caffeic acid for total phenolic acid; catechin for total flavanol and tannins; quillaja for saponins) per g of dried extract. The bioactive profile of the *B. speciosa* extracts was determined while using a Dionex Ultimate 3000RS UHPLC instrument. All of the analytical and chromatographic details are given in [Supplemental Materials](#app1-antioxidants-09-00128){ref-type="app"}. *B. speciosa* water and methanol extracts (5 µg/mL) were also analyzed for accurate phenolic quantitative determination of epicatechin, catechin, and gallic acid while using a reversed phase HPLC-fluorimetric in gradient elution mode, as recently described \[[@B22-antioxidants-09-00128]\]. The experimental details are given in [Supplemental Materials](#app1-antioxidants-09-00128){ref-type="app"}.

2.4. Determination of Antioxidant and Enzyme Inhibitory Effects {#sec2dot4-antioxidants-09-00128}
---------------------------------------------------------------

For antioxidant capacity, different test systems, including radical quenching, reducing power, phosphomolybdenum, and ferrous ion chelating, were used. The methods details were described in our earlier paper \[[@B23-antioxidants-09-00128]\]. Standard trolox and EDTA equivalents were selected as standards to explain results. For enzyme inhibitory effects, key enzymes for global health problems were selected, namely α-amylase and α-glucosidase, acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and tyrosinase. Similar to the antioxidant assays, standard equivalent method (acarbose for amylase and glucosidase; galatamine for AChE and BChE; kojic acid for tyrosinase) was selected \[[@B23-antioxidants-09-00128]\]. Experimental details are given in the [Supplemental Materials](#app1-antioxidants-09-00128){ref-type="app"}.

2.5. Antimicrobial and Antimycotic Assays {#sec2dot5-antioxidants-09-00128}
-----------------------------------------

Antibiotic and antimycotic assays were performed according to our previous studies \[[@B24-antioxidants-09-00128],[@B25-antioxidants-09-00128]\]. The detailed description is reported in the [Supplementary Material](#app1-antioxidants-09-00128){ref-type="app"}.

2.6. Cell lines and Treatments {#sec2dot6-antioxidants-09-00128}
------------------------------

Human hepatocellular carcinoma HepG2 cells were cultured in DMEM (Sigma, St. Louis, MO, USA) that was supplemented with 10% FBS at 37 °C, 5% CO~2~. *B. speciosa* methanol and water extracts were solubilized in phosphate-buffered saline (PBS) by sonication and then centrifuged at 1200 rpm for five minutes to remove the insoluble fraction. Supernatants were filtered through 0.2 μm pore diameter filters (Euroclone).

2.7. Cell Viability Assay {#sec2dot7-antioxidants-09-00128}
-------------------------

Cell viability was tested by MTT assay \[3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide; Sigma, St. Louis, MO, USA\]. Briefly, the HepG2 cells were seeded in 96-well plates (5 × 103 cells/well) and they were treated the following day for 24, 48, or 72 hours with *B. speciosa* methanol and water extracts at various concentrations as indicated, or with vehicle (control). The MTT assay was performed as previously described \[[@B26-antioxidants-09-00128]\]. The IC~50~ values were calculated while using the CompuSyn software.

2.8. Ex Vivo Studies {#sec2dot8-antioxidants-09-00128}
--------------------

Sprague--Dawley rats (200--250 g) were sacrificed by CO~2~ inhalation (100% CO~2~ at a flow rate of 20% of the chamber volume per min) and the liver specimens were immediately collected and then maintained at 37 °C for 4 h in RPMI that was supplemented with *E. coli* LPS (10 µg/mL). During the incubation period, liver specimens were treated with either the methanol and water extracts of *B. speciosa* (10--500 µg/mL). Afterwards, the tissues were homogenized in 50 mM perchloric acid solution for biochemical determinations, as following described. The liver dopamine (DA) and 3-hydroxy-kinurenine (3-HK) levels were analyzed through an HPLC apparatus (Jasco PU 2080-plus) coupled to electrochemical detection (ESA Coulochem III). All of the details were given in our earlier paper \[[@B27-antioxidants-09-00128]\].

2.9. Statistical Analysis {#sec2dot9-antioxidants-09-00128}
-------------------------

The results are given as mean ± S.D. One-way analysis of variance (ANOVA) with post-hoc Tukey test was conducted to determine significant differences (in total bioactive compounds, antioxidant, and enzyme inhibitory assays) between the extracts. ANOVA coupled to Newman--Keuls post-hoc test was employed for statistical analysis of data in pharmacological in vitro and ex vivo assays. GraphPad Prism 5.01 software was used to perform all of the statistical analyses. The results were considered to be statistically significant at *p* \< 0.05.

3. Results and Discussion {#sec3-antioxidants-09-00128}
=========================

While the term "phenolic compounds" includes a broad group of molecules containing at least one phenol unit, different other subgroups, such as flavonoids, tannins, and phenolic acids, among others, can be defined based on their chemical structures \[[@B28-antioxidants-09-00128]\]. In the current work, the content of major phytochemical groups from *B. speciosa* stem bark extracts was evaluated while using spectrophotometric methods and are summarized in [Table 1](#antioxidants-09-00128-t001){ref-type="table"}. The best concentration of flavanols, tannins, and saponins was observed in the *B. speciosa* stem bark methanol extract, whereas the highest flavonoid content was obtained in ethyl acetate extract. Flavonoids encompass a group of secondary metabolites having a distinct polyphenolic structure that consists of 15-carbon skeleton (two phenyl rings and one heterocyclic ring) \[[@B29-antioxidants-09-00128]\]. On the other hand, flavanols or flavan-3-ols, which represent a popular group of flavonoids, include epicatechin and catechin, and their polymerization products \[[@B30-antioxidants-09-00128]\]. Phenolic acids, which are the most widely distributed plant non-flavonoid phenolic compounds \[[@B31-antioxidants-09-00128]\], carboxylic acids derivatives of either benzoic or cinnamic acid skeletons \[[@B32-antioxidants-09-00128]\], were not identified from the ethyl acetate extract. However, HPLC-MS/MS was employed to more accurately evaluate the phytocomposition of *B. speciosa* stem bark extracts while considering the limitations of spectrophotometric determination in the assessment of phytocompound composition of herbal extract. With regards to the different extracts, 36 compounds were identified from the ethyl acetate extract, 44 from the methanol and 38 from the water extract of *B. speciosa* stem bark ([Table 2](#antioxidants-09-00128-t002){ref-type="table"}). Ellagic, quinic, shikimic, gallic, and ferulic acids were characterized in all of the extracts, albeit the spectrophotometric determination did not reveal the presence of phenolic acids. Corilagin, an ellagitannin, having \[M − H\]^−^ at *m/z* 633 was also characterized from all of the *B. speciosa* extracts. Mallotinic acid or its isomer, a hydrolyzable tannin \[[@B32-antioxidants-09-00128]\] having \[M − H\]^−^ at *m/z* 801, was identified from the methanol and water extracts. Bruguierol A (\[M + H\]^+^ at *m/z* 191), a dammarane triterpene \[[@B33-antioxidants-09-00128]\] and Prodelphinidin B (\[M − H\]^−^ at *m/z* 609), a polymeric tannin composed of gallocatechin, were characterized from the ethyl acetate and methanol extracts of *B. speciosa* stem bark. Tryptamine, which is a monoamine alkaloid, having \[M − H\]^−^ at *m/z* 161, was identified from the methanol extract of *B. speciosa* stem bark only. Four unidentified tannins were identified from *B. speciosa* stem bark methanol extract.

In the current work, radical scavenging, reducing power, and metal chelating assays were used to assess the antioxidant properties of *B. speciosa* stem bark extracts. This approach is believed to provide more accurate and comprehensive information regarding the antioxidant potential of herbal extracts \[[@B34-antioxidants-09-00128]\]. The methanol extract was the most active in phosphomolybdenum assay, followed by the water and the ethyl acetate extracts ([Table 3](#antioxidants-09-00128-t003){ref-type="table"}). A similar order was also obtained for total phenolic content (methanol extract \>water extract \>ethyl acetate extract). A positive correlation between concentration of phenols and antioxidant capacity was claimed in other studies, which suggests that high phenolic content could be an index of antioxidant capacity \[[@B35-antioxidants-09-00128],[@B36-antioxidants-09-00128]\]. Deleterious effects of free radicals that are mainly caused by their instability and high reactivity lead to lipid, protein, and DNA alterations, thereby triggering diseases \[[@B37-antioxidants-09-00128]\]. In line with the phosphomolybdenum assay, the methanol extract of *B. speciosa* stem bark was the most effective scavenger of DPPH (495.45 mg TE/g extract) and ABTS (902.33 mg TE/g extract). Apart from radical scavenging, the electron-donating capacity, as measured in terms of reducing power, is also regarded as an important antioxidant mechanism \[[@B38-antioxidants-09-00128]\]. The CUPRAC and FRAP are the most common methods for measuring reducing power, in vitro. The FRAP evaluates the ability of the herbal extract to reduce ferric to ferrous, whereas the CUPRAC assay measures the conversion of cupric to cuprous \[[@B39-antioxidants-09-00128]\]. Likewise, *B. speciosa* stem bark methanol extract showed the highest reducing activity (1325.89 and 952.68 mg TE/g extract, for CUPRAC and FRAP, respectively). However, the methanol extract (12.98 mg EDTAE/g) was the least active metal chelator. Indeed, transition metals, such as iron, can participate in Fenton reaction, converting hydrogen peroxide that is produced from mitochondrial oxidative respiration, into highly toxic hydroxyl free radical \[[@B40-antioxidants-09-00128]\]. In the current study, the ethyl acetate extract, rich in flavonoids, showed the highest metal chelating properties ([Table 3](#antioxidants-09-00128-t003){ref-type="table"}).

Most of the therapeutic drugs that are clinically available function by inhibiting a specific enzyme \[[@B41-antioxidants-09-00128]\]. Today, the challenge is to find novel inhibitors that can effectively correct metabolic imbalances, without causing side effects. The ability of *B. speciosa* stem bark extracts to inhibit cholinesterases, tyrosinase, α-amylase, and α-glucosidase was assessed and is reported in [Table 4](#antioxidants-09-00128-t004){ref-type="table"}. The inhibition of cholinesterases, namely acetylcholinesterase and butyrylcholinesterase, remains the main focus for the management of Alzheimer's disease. Besides, an increasing number of publications and clinical studies substantiates that Alzheimer's disease and type 2 diabetes might share some pathophysiological similarities \[[@B42-antioxidants-09-00128],[@B43-antioxidants-09-00128]\]. As such, type 2 diabetes has been identified as a risk factor for Alzheimer's disease based on multiple connections \[[@B44-antioxidants-09-00128]\]. From [Table 4](#antioxidants-09-00128-t004){ref-type="table"}, it was noted that *B. speciosa* stem bark methanol extract exhibited the highest inhibition against acetylcholinesterase (4.98 mg GALAE/g extract) and butyrylcholinesterase (5.14 mg GALAE/g extract). The extracts showed a relatively low inhibition against α-amylase (ranging from 0.59 to 1.20 mmol ACAE/g extract), whereas only the ethyl acetate extract (3.56 mmol ACAE/g extract) actively inhibited α-glucosidase. Tyrosinase inhibition is the main therapeutic strategy for the management of epidermal hyperpigmentation conditions. The methanol extract (157.25 mg KAE/g extract) of *B. speciosa* stem bark showed highest inhibitory activity against tyrosinase. The observed enzyme inhibitory activity of *B. speciosa* stem bark methanol extract might be related to more than one phytochemical that is present in the extracts. Interestingly, molecular docking studies have previously shown that mangiferin effectively binds to acetylcholinesterase and butyrylcholinesterase \[[@B45-antioxidants-09-00128]\]. Ferulic acid was reported to hybridise with quinoline in a competitive manner. Carbazole was reported to be more potent than galantamine, which showed pronounced inhibition against cholinesterases \[[@B46-antioxidants-09-00128],[@B47-antioxidants-09-00128]\]. On the other hand, it was also reported that corilagin (IC~50~ = 1.231 mM) was active against tyrosinase \[[@B48-antioxidants-09-00128]\]. Mangiferin was reported to exert a non-competitive inhibition of α-glucosidase \[[@B49-antioxidants-09-00128]\].

The methanol and water extracts were selected for further biological assays based on the results of colorimetric analyses indicating a more promising phytochemical profile in terms of total phenols and antiradical activity. A microbiological study was carried out to investigate the potential anti-fungal and anti-bacterial effects of selected pathogen strains, which are fully described in [Supplementary Materials](#app1-antioxidants-09-00128){ref-type="app"}. The anti-microbial effects of both water and methanol extracts were compared with reference drugs and presented in [Table 5](#antioxidants-09-00128-t005){ref-type="table"} and [Table 6](#antioxidants-09-00128-t006){ref-type="table"}. The results clearly demonstrated that the extracts were less effective when compared to the reference drugs, namely the anti-mycotics fluconazole and griseofulvin and the anti-bacterial ciprofloxacin. Nevertheless, the methanol extract of *B. speciosa* displayed anti-mycotic activity on *C. albicans* (YEPGA 6379) that deserves further investigation. This inhibitory effect is consistent with its major content in total phenolic compounds \[[@B24-antioxidants-09-00128],[@B25-antioxidants-09-00128]\], as confirmed by both colorimetric assays ([Table 1](#antioxidants-09-00128-t001){ref-type="table"}) and independent HPLC-fluorimetric analysis ([Table 7](#antioxidants-09-00128-t007){ref-type="table"}). While considering both the incidence of *C. albicans* opportunistic infections occurring in liver disorders \[[@B50-antioxidants-09-00128]\] and the traditional use of *Bridelia* genus \[[@B9-antioxidants-09-00128]\], a pharmacological investigation was subsequently performed to explore anti-proliferative effects against the liver cancer HepG2 cell line and protective effects on isolated rat liver specimens challenged with the LPS pro-inflammatory stimulus. The HepG2 cell viability was evaluated through the MTT test, which revealed a stimulatory effect induced by methanol extract, up to 48 hours following treatment ([Figure 1](#antioxidants-09-00128-f001){ref-type="fig"}). Conversely, the water extract of *B. speciosa* was able to reduce cell viability in the concentration range (300--500 µg/mL) throughout the 72 hour treatment ([Figure 1](#antioxidants-09-00128-f001){ref-type="fig"}), thus indicating significant anti-proliferative effects that are consistent with more than one speculation. On one side, the concentration-dependent anti-proliferative effects that were exerted by the water extract could be related to epicatechins \[[@B51-antioxidants-09-00128]\]. This was, at least in part, confirmed by the mild anti-proliferative effect that was exerted by the sole epicatechin (100 µg/mL) (CTR: 100; Epicatechin: 87.88 ± 4.35). On the other hand, we cannot exclude that the stimulating effect induced by methanol extract depends on its major content in phenolic compounds ([Table 1](#antioxidants-09-00128-t001){ref-type="table"} and [Table 7](#antioxidants-09-00128-t007){ref-type="table"}), with particular regards to gallic acid, which could also exert putative pro-oxidant effects \[[@B22-antioxidants-09-00128],[@B52-antioxidants-09-00128]\], thus potentially contributing to the maintenance of a microenvironment favorable to the proliferation of a cancer cell line \[[@B24-antioxidants-09-00128]\]. Protective effects following extract treatment were also evaluated in a toxicological model constituted by isolated liver specimens that were stimulated with LPS, which increased the 3-HK levels in the liver tissue ([Figure 2](#antioxidants-09-00128-f002){ref-type="fig"}). 3-HK is a kinurenine-3-monooxygenase (KMO)-deriving kinurenine metabolite that is able to induce oxidative stress in multiple tissues, including the brain and pancreas \[[@B53-antioxidants-09-00128],[@B54-antioxidants-09-00128]\]. Additionally, increased KMO activity was described in rodent models of acute pancreatitis \[[@B53-antioxidants-09-00128]\], despite that there is still a lack of scientific evidence about KMO activity and 3-HK level in inflamed liver. Conversely, liver dopamine (DA) levels were reduced in the same experimental condition ([Figure 3](#antioxidants-09-00128-f003){ref-type="fig"}). Besides its crucial role as neurotransmitter in the central nervous system, recent findings suggest anti-inflammatory and protective effects that are induced by DA administration in experimental models of acute pancreatitis and hepatitis \[[@B55-antioxidants-09-00128],[@B56-antioxidants-09-00128]\]. Consistent with the observed antiradical activity, both of the extracts reduced the LPS-induced levels of 3-HK ([Figure 2](#antioxidants-09-00128-f002){ref-type="fig"}). On the other hand, the water extract was completely ineffective against the LPS-induced levels of DA, thus ruling out the involvement of DA in mediating extract anti-oxidant effects, in the liver. By contrast, the methanol extract displayed a significant stimulating effect on liver DA concentration ([Figure 3](#antioxidants-09-00128-f003){ref-type="fig"}). This protective effect is consistent with both the antioxidant effect that is exerted by the extract and with literature \[[@B22-antioxidants-09-00128],[@B27-antioxidants-09-00128]\]. Overall, the present pharmacological assays suggest that *B. speciosa* could be considered as a source of natural compounds with potential application in liver inflammation and cancer.

4. Conclusions {#sec4-antioxidants-09-00128}
==============

This is the first report regarding the biological and phytochemical profiles of *B. speciosa* stem bark extracts. In this respect, our findings can be considered as the first attempt to provide new scientific information on the *Bridelia* genus. Among the three extracts studied, the methanol extract showed antioxidant and inhibitory properties against enzymes that are related to Alzheimer's disease and epidermal hyperpigmentation conditions. The antioxidant effects displayed by the methanol extract were also consistent with the observed protective effects in the liver and the anti-mycotic effect against the *C. albicans* (YEPGA 6379) strain. The protective effects on rat liver induced by methanol extract were also substantiated by the increased DA and reduced 3-HK levels. On the other hand, the water extract reduced the HepG2 cell viability, thus suggesting potential anti-proliferative effects. Several compounds identified and quantified in the *B. speciosa* stem bark water and methanol extracts, including gallic acid and catechins, might be responsible for the observed effects. Therefore, the isolation of compounds from the methanol and water extracts is required for the validation of the observed pharmacological investigations. To sum up, our findings suggest that *B. speciosa* barks may be a key bio-resource for the development of novel pharmaceuticals or cosmeceuticals. Further studies are strongly recommended for exploring more biological properties through in vivo animal studies.

The experiments were approved by Local Ethical Committee (University "G. d'Annunzio" of Chieti-Pescara) and Italian Health Ministry (Italian Health Ministry authorization N. F4738.N.XTQ, delivered on 11 November 2018).

The following are available online at <https://www.mdpi.com/2076-3921/9/2/128/s1>. Supplementary Materials and Methods; CFF-strains.
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![*B. speciosa* methanol and water extracts affect cell viability in human hepatocellular carcinoma HepG2. Cell viability was assessed by MTT assay after incubation for 24, 48, or 72 h, with the extracts at various concentrations as indicated, or with vehicle (control). Data shown are the means + SD of two independent experiments with quadruplicate determinations. Statistical analyses were performed using GraphPad Prism version 5.01 software (San Diego, CA). Comparisons of mean values between control and each drug concentration were performed by an unpaired Student's t-test. A *p*-value ≤ 0.05 was considered statistically significant (\* *p* \< 0.05; \*\* *p* \< 0.01; \*\*\* *p* \< 0.001).](antioxidants-09-00128-g001){#antioxidants-09-00128-f001}

![Effects of *B. speciosa* methanol and water extracts on LPS-induced 3-HK level in isolated rat liver specimens. ANOVA, *p* \< 0.0001; \*\* *p* \< 0.01, *\*\*\* p \<* 0.001 vs. LPS control group.](antioxidants-09-00128-g002){#antioxidants-09-00128-f002}

![Effects of *B. speciosa* methanol and water extracts on LPS-induced DA level in isolated rat liver specimens. ANOVA, *p* \< 0.001; \* *p* \< 0.05, *\*\* p \<* 0.01 vs. LPS control group.](antioxidants-09-00128-g003){#antioxidants-09-00128-f003}

antioxidants-09-00128-t001_Table 1

###### 

Total bioactive components of the tested samples.

  Samples   Total phenolic Content (mg GAE/g Extract)   Total Flavonoid Content (mg RE/g Extract)   Total Phenolic Acid Content (mg CAE/g)   Total Flavanol Content (mg CE/g)   Total Tannin Content (mg CE/g)   Total Saponin Content (mg QE/g)
  --------- ------------------------------------------- ------------------------------------------- ---------------------------------------- ---------------------------------- -------------------------------- ---------------------------------
  EA        38.42 ± 0.38 ^c^                            5.85 ± 0.12 ^a^                             nd                                       3.61 ± 0.02^c^                     3.28 ± 0.38 ^c^                  177.82 ± 14.15 ^c^
  MeOH      224.28 ± 1.08 ^a^                           1.51 ± 0.04 ^b^                             11.55 ± 1.31 ^b^                         246.28 ± 10.63 ^a^                 324.09 ± 10.99 ^a^               1031.45 ± 48.83 ^a^
  Water     210.29 ± 0.71 ^b^                           1.44 ± 0.17 ^b^                             13.91 ± 0.42 ^a^                         6.15 ± 0.18 ^b^                    67.83 ± 3.64 ^b^                 772.56 ± 56.39 ^b^

Values expressed are means ± S.D. of three parallel measurements. GAE: Gallic acid equivalent; RE: Rutin equivalent; CE: catechin equivalent; CAE: caffeic acid equivalent; QE: Quillaja equivalent; EA: Ethyl acetate; MeOH: Methanol; nd: not detected. Different letters indicate significant differences in the extracts (*p* \< 0.05).

antioxidants-09-00128-t002_Table 2

###### 

Chemical composition of the tested extracts.

  No.      Name                                                     Class ^3^   Formula      Rt ± 0.03 min   \[M + H\]^+^   \[M − H\]^−^   Fragment 1   Fragment 2   Fragment 3   Fragment 4   Fragment 5   Detected in Extract ^2^
  -------- -------------------------------------------------------- ----------- ------------ --------------- -------------- -------------- ------------ ------------ ------------ ------------ ------------ -------------------------
  1        Quinic acid                                              a           C7H12O6      1.23                           191.05557      173.0447     127.0388     111.0438     93.0331      85.0280      A,B,C
  2        Shikimic acid                                            a           C7H10O5      1.31                           173.04500      155.0338     137.0234     111.0439     93.0331      73.0280      A,B,C
  3        Citric acid                                              a           C6H8O7       1.57                           191.01918      173.0082     129.0181     111.0074     87.0073      85.0280      B,C
  4        Prodelphinidin B                                         b           C30H26O14    1.73                           609.12444      441.083      423.073      305.0672     177.0185     125.0231     B,C
  5 ^1^    Gallic acid (3,4,5-Trihydroxybenzoic acid)               c           C7H6O5       2.29                           169.0137       125.0231     97.0282      81.0332      79.0175      69.0329      A,B,C
  6        Gallocatechin (Casuarin, Gallocatechol)                  d           C15H14O7     4.52                           305.06613      261.0767     219.0651     167.0341     137.0234     125.0232     A,B,C
  7 ^1^    Tryptamine                                               e           C10H12N2     8.44            161.107875                    144.0810     143.0732     117.0703     115.0546     103.0547     B,C
  8        Syringic acid-4-O-glucoside                              f           C15H20O10    10.57                          359.09783      197.0451     182.0214     153.0546     138.031      123.0073     C
  9 ^1^    Catechin (Catechol, Catechuic acid)                      d           C15H14O6     13.28                          289.07121      245.082      203.0711     151.0389     125.0233     109.028      B,C
  10 ^1^   Epigallocatechin (Epigallocatechol)                      d           C15H14O7     13.57                          305.06613      261.0767     219.0658     167.0339     137.0234     125.0232     A,B,C
  11 ^1^   Vanillin (4-Hydroxy-3-methoxybenzaldehyde)               g           C8H8O3       15.47           153.05517                     125.0601     111.0445     110.0367     93.0341      65.0393      A,B,C
  12 ^1^   Epigallocatechin-3-O-gallate (Teatannin II)              d           C22H18O11    16.39                          457.07709      305.0661     169.0131     161.0238     125.0231                  A,B,C
  13 ^1^   Gallocatechin-3-O-gallate                                d           C22H18O11    16.40                          457.07709      305.067      169.0133     161.0233     125.0231                  C
  14       Dihydrokaempferol-O-hexoside                             d           C21H22O11    17.02                          449.10839      287.0568     269.0447     259.0607     125.023                   A,B,C
  15 ^1^   Epicatechin                                              d           C15H14O6     17.04                          289.07121      245.0818     203.0706     151.0388     125.0231     109.028      B,C
  16       3,5-Dimethoxy-4-hydroxybenzaldehyde (Syringaldehyde)     g           C9H10O4      17.24           183.06574                     155.0705     140.0469     123.0444     105.0341     95.0498      A,B
  17       Corilagin                                                h           C27H22O18    17.49                          633.07279      463.0526     419.0627     300.9995     275.0205     169.0134     A,B,C
  18       Mangiferin (Aphloiol, Chinonin)                          i           C19H18O11    18.41                          421.07709      343.0459     331.0464     301.0358     272.033      259.0249     A,B,C
  19       Unidentified tannin 1                                    h           C34H26O22    18.96                          785.08375      633.0741     300.9992     275.0205     125.0229                  B
  20       Ferulic acid                                             c           C10H10O4     19.25                          193.05009      178.0259     149.0594     137.023      134.0364     121.028      A,B,C
  21       Mallotinic acid or isomer                                h           C34H26O23    19.28                          801.07867      757.0872     633.0753     613.047      463.0517     300.9995     B,C
  22 ^1^   Epicatechin-3-O-gallate                                  d           C22H18O10    19.37                          441.08218      289.0725     271.0614     245.0808     169.0132     125.023      B,C
  23       Loliolide                                                j           C11H16O3     19.47           197.11777                     179.1071     161.0963     135.1172     133.1016     107.0861     A,B,C
  24       Unidentified tannin 2                                    h           C41H30O27    19.63                          953.08963      300.9994     275.02       249.0387                               B,C
  25       Ellagic acid-4-O-glucoside                               k           C20H16O13    19.90                          463.05127      300.9995     299.9915                                            A,B,C
  26       4-Hydroxy-3-methoxycinnamaldehyde (Coniferyl aldehyde)   g           C10H10O3     19.97           179.07082                     161.0599     147.0443     133.0654     119.0496     55.0187      A,B,C
  27       Unidentified tannin 3                                    h           C34H26O22    20.08                          785.08375      633.0734     300.9994     275.0207                               B
  28       Isoferulic acid                                          c           C10H10O4     20.30                          193.05009      178.0264     149.06       137.0232     134.0362     121.0283     A
  29       Unidentified tannin 4                                    h           C34H26O22    21.25                          785.08375      300.9996     275.0205     249.0402     125.0228                  B,C
  30       Myricitrin (Myricetin-3-O-rhamnoside)                    d           C21H20O12    21.96                          463.08765      317.0292     316.023      287.0213     271.0255     178.9978     B,C
  31       Di-O-methylellagic acid-O-hexoside                       k           C22H20O13    22.16                          491.08257      476.0599     328.023      312.9996     297.9761                  A,B,C
  32       Ellagic acid-O-pentoside                                 k           C19H14O12    22.76                          433.04071      300.9994     299.9916     283.9974     257.0082                  A,B,C
  33       Eschweilenol C (Ellagic acid-4-O-rhamnoside)             k           C20H16O12    23.09                          447.05636      300.9994     299.9916                                            A,B,C
  34       Pentahydroxyflavone-C-hexoside                           d           C21H20O12    23.11           465.10331                     447.0935     429.0806     369.0611     327.0503     303.0504     A
  35       Ellagic acid                                             k           C14H6O8      23.38                          300.99845      283.9967     257.0094     229.0138     201.0187     185.0237     A,B,C
  36       Dimethoxy-trihydroxyflavone-O-hexoside                   d           C23H24O12    24.29                          491.11895      328.0586     313.0352     299.0195     285.0397     271.0252     B,C
  37       Di-O-methylflavellagic acid O-hexoside                   k           C21H18O13    24.70                          507.07749      344.0187     328.994      313.97                                 A
  38       Ducheside A (3-O-Methylellagic acid-4′-O-xyloside)       k           C20H16O12    24.74                          447.05636      315.0151     314.0074     299.9917     298.983      270.9886     A,B,C
  39       3,3′-Di-O-methylellagic acid-O-pentoside                 k           C21H18O12    25.32                          461.07201      446.0498     328.0228     312.9995     297.9757                  A,B,C
  40       3,3′,4-Tri-O-methylflavellagic acid-4-O-glucoside        k           C23H22O14    25.55                          521.09314      506.0705     491.0473     358.0327     343.0098     327.9864     A,B,C
  41       Eschweilenol A or isomer                                 k           C20H10O11    25.90                          425.01449      300.9993     299.9917     298.9837                               B
  42       Dihydroactinidiolide                                     j           C11H16O2     26.58           181.12286                     163.112      145.1015     135.1172     121.1015     107.0861     A,B,C
  43       Di-O-methylellagic acid acetylhexoside                   k           C24H22O14    27.49                          533.09313      328.0231     312.9999     297.9756     269.9827                  A
  44       3,3′-Di-O-methylellagic acid                             k           C16H10O8     27.84                          329.02975      314.0073     298.9837     270.9887                               A,B,C
  45       Sebacic acid                                             a           C10H18O4     27.96                          201.11268      183.102      157.1229     139.1117     111.0801                  A
  46       3,3′,4-Tri-O-methylellagic acid                          k           C17H12O8     30.18                          343.0454       328.0231     312.9995     297.9758     285.0038                  A
  47       Undecanedioic acid                                       a           C11H20O4     30.85                          215.12834      153.1273     125.0956                                            A
  48       3,3′,4-Tri-O-methylflavellagic acid                      k           C17H12O9     31.21                          359.04031      344.0171     328.9948     313.9717     300.9995                  A,B,C
  49       3,3′,4,4′-Tetra-O-methylellagic acid                     k           C18H14O8     32.00           359.0767                      344.0533     343.0448     329.0295     313.0347                  A,B,C
  50       Dihydroxy-trimethoxyflavone                              d           C18H16O7     33.10                          343.08178      328.0585     313.0359     298.0118                               B
  51       Bruguierol A                                             l           C12H14O2     36.06           191.10721                     173.0965     161.0966     147.0801     135.0807     107.0496     A,B
  52^1^    Linoleic acid                                            a           C18H32O2     45.69                          279.23241      261.2231     59.0124                                             A,B
  53       Pheophytin A                                             m           C55H74N4O5   62.94           871.57375                     593.277      533.2559     460.2264                               A,B

^1^ Confirmed by standard. ^2^ A: Ethyl acetate extract; B: Methanol extract; C: water extract. ^3^ a: carboxylic acid; b: polyflavonoid; c: phenolic acid; d: flavonoid; e: alkaloid; f: phenolic acid glucoside; g: phenolic aldehyde; h: tannin; i: xanthon; j: benzofuran; k: benzopyrane; l: phenolic heterocycle; m: porphyrin.
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###### 

Antioxidant activities of the tested samples.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------
  Samples   Phosphomolybdenum\   DPPH\                ABTS\                CUPRAC\               FRAP\                Metal Chelating Ability (mg EDTAE/g)
            (mmol TE/g)          (mg TE/g Extract)    (mg TE/g Extract)    (mg TE/g Extract)     (mg TE/g Extract)    
  --------- -------------------- -------------------- -------------------- --------------------- -------------------- --------------------------------------
  EA        2.24 ± 0.07 ^c^      18.62 ± 0.39 ^c^     14.82 ± 0.45 ^c^     94.34 ± 0.82 ^c^      46.13 ± 0.58 ^c^     32.08 ± 1.60 ^a^

  MeOH      5.89 ± 0.37 ^a^      495.45 ± 0.53 ^a^    902.33 ± 2.41 ^a^    1325.89 ± 30.05 ^a^   952.68 ± 23.61 ^a^   12.98 ± 0.10 ^b^

  Water     5.17 ± 0.14 ^b^      463.86 ± 14.04 ^b^   581.14 ± 33.94 ^b^   1082.42 ± 3.72 ^b^    850.05 ± 5.35 ^b^    14.28 ± 2.15 ^b^
  ----------------------------------------------------------------------------------------------------------------------------------------------------------

Values expressed are means ± S.D. of three parallel measurements. TE: Trolox equivalent; EDTAE: EDTA equivalent; EA: Ethyl acetate; MeOH: Methanol. Different letters indicate significant differences in the extracts (*p* \< 0.05).
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###### 

Enzyme inhibitory properties of the tested extracts.

  ------------------------------------------------------------------------------------------------------------------------------------------
  Samples   AChE\                  BChE\                  Tyrosinase\          α-Amylase\              α-Glucosidase (mmol ACAE/g Extract)
            (mg GALAE/g Extract)   (mg GALAE/g Extract)   (mg KAE/g Extract)   (mmol ACAE/g Extract)   
  --------- ---------------------- ---------------------- -------------------- ----------------------- -------------------------------------
  EA        4.56 ± 0.20 ^b^        3.59 ± 0.05 ^b^        119.80 ± 1.30 ^c^    0.86 ± 0.03 ^b^         3.56 ± 0.03

  MeOH      4.98 ± 0.04 ^a^        5.14 ± 0.08 ^a^        157.25 ± 0.48 ^a^    1.20 ± 0.01 ^a^         na

  Water     3.60 ± 0.15 ^c^        2.61 ± 0.31 ^c^        137.49 ± 0.35 ^b^    0.59 ± 0.04 ^c^         na
  ------------------------------------------------------------------------------------------------------------------------------------------

Values expressed are means ± S.D. of three parallel measurements. AChE: acetylcholinesterase; BChE: butyrylcholinesterase; GALAE: Galantamine equivalent; KAE: Kojic acid equivalent; ACAE: Acarbose equivalent; na: not active; EA: Ethyl acetate; MeOH: Methanol. Different letters indicate significant differences in the extracts (*p* \< 0.05).
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###### 

Minimal inhibitory concentrations (MICs) of *B. speciosa* water and methanol extracts, fluconazole, and griseofulvin against clinical yeasts and dermatophytes.

                                            MIC (µg mL^−1^) \*                                
  ----------------------------------------- -------------------- --------------------- ------ -------
  *Candida albicans* (YEPGA 6183)           396.85 (250--500)    198.42 (125--250)     2      \>8
  *Candida albicans* (YEPGA 6379)           49.6 (31.25--62.5)   78.74 (62.5--125)     1      \>8
  *Candida tropicalis* (YEPGA 6184)         629.96 (500--1000)   396.85 (250--500)     4      \>8
  *Candida parapsilosis* (YEPGA 6551)       78.74 (62.5--125)    99.21 (62.5--125)     2      \>8
  *Arthroderma crocatum* (IHEM 5251)        157.49 (125--250)    78.74 (62.5--125)     8      \>8
  *Arthroderma crocatum* (CCF 5207)         99.21 (62.5--125)    78.74 (62.5--125)     \>16   \>8
  *Arthroderma insingulare* (CCF 5417)      157.49 (125--250)    39.37 (31.25--62.5)   \>16   \>8
  *Arthroderma quadrifidum* (CCF 5792)      198.42 (125--250)    78.74 (62.5--125)     \>16   \>8
  *Trichophyton erinacei* (CCF 5930)        314.98 (250--500)    157.49 (125--250)     \>16   0.25
  *Trichophyton interdigitale* (CCF 4823)   99.21 (62.5--125)    49.61 (31.25--62.5)   \>16   1
  *Trichophyton rubrum* (CCF 4879)          78.74 (62.5--125)    78.74 (62.5--125)     8      2
  *Trichophyton tonsurans* (CCF 4834)       157.49 (125--250)    39.58 (31.25--62.5)   2      0.125

\* MIC values are reported as geometric means of three independent replicates (*n* = 3); MIC range concentrations are reported within brachets. CCF, Culture Collection of Fungi, Department of Botany, Charles University, Prague, Czech Republic; IHEM, Belgian Coordinated Collections of Micro-organisms (BCCM/IHEM), Brussels, Belgium; YEPGA, yeast extract-peptone-glucose agar.
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###### 

Minimum inhibitory concentration (MIC) of *B. speciosa* extracts and ciprofloxacin towards selected bacterial strains.

                                                MIC (µg mL^−1^) \*                        
  --------------------------------------------- -------------------- -------------------- ---------------------
  *Escherichia coli* (ATCC 10536)               396.85 (250--500)    629.96 (500--1000)   \<0.12
  *Pseudomonas aeruginosa* (ATCC 15442)         629.96 (500--1000)   314.98 (250--500)    1.23 (1.95--0.98)
  *Salmonella typhimurium* (clinical isolate)   793.70 (500--1000)   793.70 (500--1000)   0.40 (0.25--0.5)
  *Bacillus cereus* (ATCC 12826)                198.42 (125--250)    157.49 (125--250)    \<0.12
  *Bacillus subtilis* (environmental isolate)   314.98 (250--500)    793.70 (500--1000)   0.01 (0.125--0.062)
  *Staphylococcus aureus* (ATCC 6538)           198.42 (125--250)    396.85 (250--500)    0.62 (0.98--0.49)

\* MIC values are reported as geometric means of three independent replicates (*n* = 3); MIC range concentrations are reported within brachets.
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###### 

Gallic acid, catechin and epicatechin level (µg/g dry extract) in methanol and water extracts of *B. speciosa.*

  Compounds     Methanol Extract   Water Extract
  ------------- ------------------ ----------------
  Gallic acid   7228.36 ± 650.55   870.28 ± 36.81
  Catechin      20.84 ± 2.51       n.d.
  Epicatechin   188.72 ± 11.32     142.71 ± 7.75

n.d.---not determined.
